AS

Apoorva Singh

Active Director Director DIN 10524613
DIN 10524613 First appointment Feb 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value •••• Premium profile

About Apoorva Singh

Data last updated:

Apoorva Singh is a Director at Uma Devi Eye Hospital Private Limited (since 2024). The company operates in Healthcare. Uma Devi Eye Hospital Private Limited reported revenue of ₹1.64 Cr (FY 2025).

DIN 10524613
Primary Designation Director
Industry Healthcare
First Appointment 28 Feb 2024
Oldest Company Age 24 yrs
Largest company Uma Devi Eye Hospital Private Limited · ₹1.64 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Feb 20242002₹1.64 Cr (FY 2025)Active

Board colleagues of Apoorva Singh

Directorship timeline

Open interactive timeline →
Uma Devi Eye Hospital Private Limited
Premium access

Shareholding and investment profile for Apoorva Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apoorva Singh

Apoorva Singh currently holds 1 directorship: Uma Devi Eye Hospital Private Limited (Director, since 28 Feb 2024, revenue ₹1.64 Cr (FY 2025)).

Apoorva Singh was first appointed on 28 Feb 2024 as Director at Uma Devi Eye Hospital Private Limited.

The current boards of Apoorva Singh's companies include Anita Sinha (Uma Devi Eye Hospital Private Limited), Deepak Kumar Singh (Uma Devi Eye Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available